These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26846349)

  • 41. IFT proteins interact with HSET to promote supernumerary centrosome clustering in mitosis.
    Vitre B; Taulet N; Guesdon A; Douanier A; Dosdane A; Cisneros M; Maurin J; Hettinger S; Anguille C; Taschner M; Lorentzen E; Delaval B
    EMBO Rep; 2020 Jun; 21(6):e49234. PubMed ID: 32270908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.
    De Iuliis F; Taglieri L; Salerno G; Giuffrida A; Milana B; Giantulli S; Carradori S; Silvestri I; Scarpa S
    Invest New Drugs; 2016 Aug; 34(4):399-406. PubMed ID: 26994617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinesin-14 motor protein KIFC1 participates in DNA synthesis and chromatin maintenance.
    Wei YL; Yang WX
    Cell Death Dis; 2019 May; 10(6):402. PubMed ID: 31127080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor activity of a kinesin inhibitor.
    Sakowicz R; Finer JT; Beraud C; Crompton A; Lewis E; Fritsch A; Lee Y; Mak J; Moody R; Turincio R; Chabala JC; Gonzales P; Roth S; Weitman S; Wood KW
    Cancer Res; 2004 May; 64(9):3276-80. PubMed ID: 15126370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma.
    De Monte C; Carradori S; Secci D; D'Ascenzio M; Guglielmi P; Mollica A; Morrone S; Scarpa S; Aglianò AM; Giantulli S; Silvestri I
    Eur J Med Chem; 2015 Nov; 105():245-62. PubMed ID: 26498571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of novel small molecule inhibitors of centrosome clustering in cancer cells.
    Kawamura E; Fielding AB; Kannan N; Balgi A; Eaves CJ; Roberge M; Dedhar S
    Oncotarget; 2013 Oct; 4(10):1763-76. PubMed ID: 24091544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis, and biological evaluation of an allosteric inhibitor of HSET that targets cancer cells with supernumerary centrosomes.
    Watts CA; Richards FM; Bender A; Bond PJ; Korb O; Kern O; Riddick M; Owen P; Myers RM; Raff J; Gergely F; Jodrell DI; Ley SV
    Chem Biol; 2013 Nov; 20(11):1399-410. PubMed ID: 24210220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells.
    Nakai R; Iida S; Takahashi T; Tsujita T; Okamoto S; Takada C; Akasaka K; Ichikawa S; Ishida H; Kusaka H; Akinaga S; Murakata C; Honda S; Nitta M; Saya H; Yamashita Y
    Cancer Res; 2009 May; 69(9):3901-9. PubMed ID: 19351824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.
    Sun Y; Zhang Y; Lang Z; Huang J; Zou Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17346. PubMed ID: 31577729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin KSP.
    Liu F; Yu LQ; Jiang C; Yang L; Wu WT; You QD
    Bioorg Med Chem; 2010 Jun; 18(12):4167-77. PubMed ID: 20537544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An Integrative Pan-Cancer Analysis of Kinesin Family Member C1 (KIFC1) in Human Tumors.
    Wu H; Duan Y; Gong S; Zhu Q; Liu X; Liu Z
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of KIFC1 and its association with spheroid formation in esophageal squamous cell carcinoma.
    Imai T; Oue N; Yamamoto Y; Asai R; Uraoka N; Sentani K; Yoshida K; Yasui W
    Pathol Res Pract; 2017 Nov; 213(11):1388-1393. PubMed ID: 28964573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stathmin/Op18 depletion induces genomic instability and leads to premature senescence in human normal fibroblasts.
    Shrestha D; Kim N; Song K
    J Cell Biochem; 2018 Feb; 119(2):2381-2395. PubMed ID: 28885720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib.
    Fleisher B; Werkman C; Jacobs B; Varkey J; Taha K; Ait-Oudhia S
    Cancer Diagn Progn; 2022; 2(5):525-532. PubMed ID: 36060015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Export of membrane proteins from the Golgi complex to the primary cilium requires the kinesin motor, KIFC1.
    Lee SH; Joo K; Jung EJ; Hong H; Seo J; Kim J
    FASEB J; 2018 Feb; 32(2):957-968. PubMed ID: 29042452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5.
    Schiemann K; Finsinger D; Zenke F; Amendt C; Knöchel T; Bruge D; Buchstaller HP; Emde U; Stähle W; Anzali S
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1491-5. PubMed ID: 20149654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and putative functions of KIFC1 for nuclear reshaping and midpiece formation during spermiogenesis of Phascolosoma esculenta.
    Gao XM; Mu DL; Hou CC; Zhu JQ; Jin S; Wang CL
    Gene; 2019 Jan; 683():169-183. PubMed ID: 30316921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual Screening.
    Zhang W; Zhai L; Lu W; Boohaker RJ; Padmalayam I; Li Y
    Chem Biol Drug Des; 2016 Aug; 88(2):178-87. PubMed ID: 26864917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5.
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2930-2938. PubMed ID: 30055887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting TAO Kinases Using a New Inhibitor Compound Delays Mitosis and Induces Mitotic Cell Death in Centrosome Amplified Breast Cancer Cells.
    Koo CY; Giacomini C; Reyes-Corral M; Olmos Y; Tavares IA; Marson CM; Linardopoulos S; Tutt AN; Morris JDH
    Mol Cancer Ther; 2017 Nov; 16(11):2410-2421. PubMed ID: 28830982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.